🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dosage of rabies immune globulin was calculated from the victim's body weig...
Status
Completed
Location
Queen Saovabha Memorial Institute, Thai Red Cross Society
Start Date
2012-06
Trial ID
NCT01610362
Treatments Being Tested
This is a Phase 3, blinded, randomized study of SYN023 compared to a China ...
Status
Completed
Location
Yunnan Province Center for Disease Control and Prevention (CDC)
Start Date
2020-09-23
Trial ID
NCT04644484
Treatments Being Tested
This is a Phase 2b, double blinded, randomized study of SYN023 compared to ...
Status
Completed
Location
University of Florida
Start Date
2019-09-03
Trial ID
NCT03961555
Treatments Being Tested
The goal of this clinical trial is to compare the efficacy and safety of GR...
Status
Completed
Location
Center for Disease Control and Prevention (CDC)
Start Date
2022-10-21
Trial ID
NCT05846568
Treatments Being Tested
The purpose of this study is to: 1. Evaluate the safety and tolerability of...
Status
Completed
Location
Prism Research Inc
Start Date
2013-04
Trial ID
NCT02040090
Treatments Being Tested
rabies mab CBB 1 is mainly used for passive immunization of patients bitten...
Status
Unknown
Location
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Start Date
2023-04-30
Trial ID
NCT05832073
This study evaluates the rabies virus neutralizing antibody (RVNA) activiti...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02559921
Primary Objective: To demonstrate that Purified Vero Rabies Vaccine - Seru...
Status
Completed
Location
Investigational Site Number 2500002
Start Date
2019-07-01
Trial ID
NCT03965962
The aim of this study is to evaluate the safety of the monoclonal antibody ...
Status
Completed
Location
MDS Pharma Services , USA
Start Date
2008-03
Trial ID
NCT00656097
Treatments Being Tested
Primary Objective: To describe the immune response induced by VRVg-2 and V...
Status
Completed
Location
Investigational site number 7640002
Start Date
2020-10-11
Trial ID
NCT04594551